Loss-making Lotte Chemical to sell water treatment unit to Synopex
Lotte Chemical Corp., South Korea’s second-largest petrochemical company grappling with mounting losses amid a prolonged industry downturn, wi...
South Korea’s Rznomics inks $1.3 bn out-licensing deal with Eli Lilly
Rznomics Inc., a South Korean RNA therapeutics developer, has signed an agreement worth more than $1.3 billion with US pharmaceutical giant Eli Lill...
Celltrion wins EU approval for autoimmune disease treatment Avtozma
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
SK Ecoplant seeks to sell waste treatment business for $1.4 billion
SK Ecoplant Co., a South Korean construction engineering and waste management company under SK Group, is seeking to dispose of its waste treatment b...
LG Chem embarks on sale of dermal filler business worth $343 million
LG Chem Ltd., the world’s fourth-largest chemicals producer that is fostering vaccine and new drug development as new growth drivers, has kick...
Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe
South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Celltrion obtains approval of Steqeyma from FDA
South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...
SK Pharmteco bags obesity treatment deal worth up to $1.4 bn
SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...
Celltrion gets approval of Omlyclo in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...
LG Energy to supply 2170-type cells to Bear Robotics
South Korea’s LG Energy Solution Ltd. said on Monday it has signed an initial agreement to supply cylindrical battery cells to Bear Robotics I...
Celltrion releases Steqeyma in Europe
South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...
DS Dansuk wins $750 mn SAF material order from Phillips 66
South Korea's DS Dansuk Co., which operates bioenergy, battery, and plastic recycling businesses, said on Monday it signed a 1 trillion won ($750 mi...
ViGenCell obtains approval for HLA-B5801 genetic diagnostic kit for adverse reactions to gout treatment
ViGenCell, a company specializing in immunotherapy, announced on Friday that it has obtained approval from the Ministry of Food and Drug Safety (MFD...
Mirae Asset's retirement pension reserves rise by $2.9 bn in 2024
South Korea's Mirae Asset Securities Co. said on Tuesday that its defined contribution (DC) retirement pension and individual retirement pension (IR...
Celltrion's anti cancer drugs hold 90% market share in C.America
South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....
LG Energy aims to more than double sales to $50 billion by 2028
LG Energy Solution Ltd. has vowed to more than double its sales in five years to 67 trillion won ($50 billion) by diversifying its battery products ...
Hanwha Galleria acquires beverage manufacturer Pure Plus
South Korea's Hanwha Galleria Corp. said on Monday its acquisition of domestic beverage manufacturer Pure Plus.Pure Plus has focused on non-alcoholi...
Osstem Implant to boost digital dentistry business
South Korea's Osstem Implant Co., the world’s fourth-largest dental implant maker, will enhance its software system of digital dentistry. ...
Taihan Cable enters HVDC market in US
South Korea's Taihan Cable & Solution Co. said on Thursday that it was selected as the cable supplier for a 320kV voltage-type high-voltage dire...
Celltrion to supply breast, stomach cancer treatment to Brazil
Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...
SK Group’s 3rd-generation daughter comes to the fore
Chey Yoon-chung, the eldest daughter of SK Group Chairman Chey Tae-won, unexpectedly made her debut during an SK Biopharmaceuticals Co. video confer...
Korea Investment's Nasdaq 100 ETF surpasses $747 mn
Korea Investment Management Co. said on Thursday that the net assets of its ACE US Nasdaq 100 Exchange-Traded Fund (ETF) had surpassed 1 trillion wo...
Bibigo dumplings enters New Zealand food market
South Korea's CJ CheilJedang Corp. announced on Wednesday that it will launch Bibigo dumplings at supermarket chains New World and PAK’nSAVE i...
GS E&C in talks to sell entire stake in GS Elevator to Chinese firm
South Korea’s GS Engineering & Construction Corp. (GS E&C) is in talks to sell its entire stake in GS Elevator Co. to a Chinese strate...
Celltrion gets approval of Steqeyma in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...
Lotte Wellfood expands dairy exports to Vietnam
South Korea's Lotte Wellfood Co. announced on Thursday that it will increase dairy exports to the Vietnamese market.The products newly exported to V...
Young Korean investors choose monthly dividend ETFs over crypto
For decades, investments in financial products that promise decent dividend payouts such as high-dividend stocks have been associated with elderly i...
Samsung Asset publishes brokerage ISA guidebook
South Korea's Samsung Asset Management announced on Thursday that it newly published the KODEX Brokerage ISA Investment Guidebook for individual inv...
GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn
South Korea’s GC Biopharma Corp. announced on Wednesday that it signed a share purchase agreement (SPA) to sell all its shares in its Hong Kon...
